Frontlight ResearchEarly access
Trial site
Universitaetsklinikum Allgemeines Krankenhaus Wien
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Obesity4 trials
- Colorectal cancer2 trials
- Heart failure2 trials
- Metastatic breast cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Lung cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- and 5 more
- Phase
- Phase 312 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting8 trials
- Recruiting3 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Amgen7 trials
- Eli Lilly and Company7 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure1 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Recruiting
Completed
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026